SPSMEDICAL SPORVIEW BACTERIAL SPORE STRIP

K023716 · Spsmedical Supply Corp. · FRC · Dec 5, 2002 · General Hospital

Device Facts

Record IDK023716
Device NameSPSMEDICAL SPORVIEW BACTERIAL SPORE STRIP
ApplicantSpsmedical Supply Corp.
Product CodeFRC · General Hospital
Decision DateDec 5, 2002
DecisionSESE
Submission TypeSpecial
Regulation21 CFR 880.2800
Device ClassClass 2

Intended Use

The SPSmedical SporView® Bacterial Spore Strip is designed for routine monitoring of Steam, Dry Heat, EO Gas, and Chemiclave® sterilization processes. For steam sterilizers operating at 121℃ and at 132℃ a 24 hour incubation time has been validated. The indicator should be placed in the most difficult to sterilize location of the sterilization load. After cycle completion, the spore strip is removed from the load and aseptically transferred into SPSmedical's SporView® Culture Media (Tryptic Soy Broth with Bromocresol Purple) and incubated at 60°C. The combination of SPSmedical's spore strip and media has been validated for a reduced incubation time of 24 hours for steam processes. For Dry Heat, EO Gas, or Chemiclave® sterilization processes, the incubation period is seven (7) days

Device Story

Biological indicator for sterilization monitoring; consists of Whatman 3MM chromatography filter paper inoculated with Geobacillus stearothermophilus (and optionally Bacillus atrophaeus) spores; packaged in blue glassine envelope. Device placed in most difficult-to-sterilize location of sterilization load. Post-cycle, strip transferred to SporView® Culture Media (Tryptic Soy Broth with Bromocresol Purple) and incubated at 60°C. Visual observation of media color change indicates presence of surviving spores; confirms sterilization failure or success. Enables 24-hour reduced incubation time for steam processes; 7-day incubation for other methods. Used in clinical settings to ensure equipment sterility and patient safety.

Clinical Evidence

Bench testing only. Validation performed per FDA guidance for reduced incubation of biological indicators. Tested three lots (new, mid-range, and near-expiration) using SporView® Culture Media. Results confirmed 24-hour reduced incubation time for steam sterilization processes.

Technological Characteristics

Whatman 3MM chromatography filter paper substrate; inoculated with Geobacillus stearothermophilus ATCC# 7953 or dual species with Bacillus atrophaeus ATCC# 9372. Packaged in blue glassine envelope. Requires external incubation at 60°C in Tryptic Soy Broth with Bromocresol Purple.

Indications for Use

Indicated for monitoring steam sterilization cycles at 121°C and 132°C, as well as Dry Heat, EO Gas, and Chemiclave® processes. Used by clinical staff to verify sterilization efficacy.

Regulatory Classification

Identification

Biological sterilization process indicator: A device intended for use by a health care provider to accompany products being sterilized through a sterilization procedure and to monitor adequacy of sterilization. The device consists of a known number of microorganisms, of known resistance to the mode of sterilization, in or on a carrier and enclosed in a protective package. Subsequent growth or failure of the microorganisms to grow under suitable conditions indicates the adequacy of sterilization. Physical/chemical sterilization process indicator: A device intended for use by a health care provider to accompany products being sterilized through a sterilization procedure and to monitor one or more parameters of the sterilization process. The adequacy of the sterilization conditions as measured by these parameters is indicated by a visible change in the device.

Predicate Devices

Related Devices

Submission Summary (Full Text)

{0}------------------------------------------------ Ko23716 # 510(k) Summary of Safety and Effectiveness # Submitter: DEC 0 5 2002 - SPSmedical Supply Corp. . 6789 West Henrietta Road Rush, NY 14543 U.S.A. Phone: (585)-359-0130 Fax: (585)-359-0167 - Establishment FDA Registration No.: 1319130 . - Date Summary was Prepared November 1st, 2002 ● - Gary J. Socola ● Printed name of person sybmitting for 510(k) - are . Signature of person submitting for 510(k) - Director of Quality Assurance . Title of person submitting for 510(k) ## Device Name and Classification | Trade Name: | SPSmedical SporView® Bacterial Spore Strip | |------------------------|------------------------------------------------------| | Classification Name: | Sterilization Process Biological Indicator | | Common Name: | Spore Strip Biological Indicator | | Device Classification: | Class II, Regulation Number 880.2800 | | Product Code: | FRC | | Predicate Device: | SPSmedical SporView® Bacterial Spore Strip (K905425) | {1}------------------------------------------------ #### Device Description: The SPSmedical SporView® Bacterial Spore Strip is a .250" x 1 1/2" Whatman 3MM chromatography filter paper inoculated with either a single species (Geobacillus stearothermophilus ATCC# 7953) or a dual species (Geobacillus stearothermophilus ATCC# 7953 and Bacillus atrophaeus ATTC# 9372) bacterial spores. The strip is packaged in a blue glassine envelope. ### Intended Use: The SPSmedical SporView® Bacterial Spore Strip is designed for routine monitoring of Steam, Dry Heat, EO Gas, and Chemiclave® sterilization processes. For steam sterilizers operating at 121℃ and at 132℃ a 24 hour incubation time has been validated. The indicator should be placed in the most difficult to sterilize location of the sterilization load. After cycle completion, the spore strip is removed from the load and aseptically transferred into SPSmedical's SporView® Culture Media (Tryptic Soy Broth with Bromocresol Purple) and incubated at 60°C. The combination of SPSmedical's spore strip and media has been validated for a reduced incubation time of 24 hours for steam processes. For Dry Heat, EO Gas, or Chemiclave® sterilization processes, the incubation period is seven (7) days Statement of Similarity to the Leqally Marketed Predicate Device: - Have the same indicated use . - Incorporate the same materials . - Have the same shelf life . - Packaged using the same materials and processes . #### Non-Clinical Testing: Testing was conducted following the FDA guidance for the validation of reduced incubation of biological indicators. Testing was performed for the steam sterilization process using three lots of biological indicators; this included a newly manufactured lot, mid-range expiration lot and a lot nearing its expiration date. All lots were tested using SPSmedical's SporView® Culture Media (Tryptic Soy Broth, Modified with Bromocresol Purple). All lots tested resulted in a 24 hour reduced incubation time for the steam sterilization process when using the combination of the SPSmedical SporView® Bacterial Spore Strip and the SPSmedical's SporView® Culture Media. #### Conclusion: Supportive data has demonstrated that the SPSmedical SporView® Bacterial Spore Strip is equivalent to the legally marketed predicate device. Results of performance testing validate that the SPSmedical SporView® Bacterial Spore Strip provides a 24 hour reduced incubation time when used with the SPSmedical SporView® Culture Media in monitoring the steam sterilization process. {2}------------------------------------------------ ## DEPARTMENT OF HEALTH & HUMAN SERVICES Image /page/2/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo features a stylized caduceus symbol, which is often associated with healthcare. The words "DEPARTMENT OF HEALTH & HUMAN SERVICES USA" are arranged in a circular pattern around the symbol. The logo is black and white. Food and Drug Administratio 9200 Corporate Boulevard Rockville MD 20850 Mr. Gary J. Socola Director, Quality Assurance SPSmedical Supply Corporation 6789 West Henrietta Road Rush, New York 14543 Re: K023716 Trade/Device Name: SPSmedical SporView® Bacterial Strip Regulation Number: 880.2800 Regulation Name: Sterilization Process Indicator Regulatory Class: II Product Code: FRC Dated: November 1, 2002 Received: November 5, 2002 Dear Mr. Socola: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition. FDA may publish further announcements concerning your device in the Federal Register. {3}------------------------------------------------ #### Page 2 -- Mr. Socola Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (301) 594-4618 . Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers. International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html Sincerely vours. f. Akilestolansen for; Timothy A. Ulatowski Director Division of Anesthesiology, General Hospital, Infection Control and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health {4}------------------------------------------------ # INDICATIONS for USE STATEM SPSmedical Supply Corp. Applicant: 510(k) Number (if known): _ Device Name: SPSmedical SporView® Bacterial Spore Strip Indications For Use: The SPSmedical SporView® Bacterial Spore Strip is designed to monitor steam sterilizer The combination of SPSmedical's spore strip and cycles at 121°C and 132°C. Sportiew® Culture Media (Tryptic Soy Broth, Modified with Bromocresol Purple) has Oper notice of 60°C for a reduced incubation time of 24 hours for steam sterilization processes. Quy Lim (Division Sign-Off) Division of Anesthesiology, General Hospital, Infection Control, Dental D 510(k) Number: 0 (PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE) (Per 21 CFR 801.109)
Innolitics
510(k) Summary
Decision Summary
Classification Order
Enter a record ID and click Load to view the document.
100%